Results 181 to 190 of about 338,947 (383)
Delayed skin reaction to human dander in atopic dermatitis.
Masami Uehara, Shigeo Ofuji
openalex +2 more sources
Impairment of the autologous mixed lymphocyte reaction in atopic dermatitis. [PDF]
Donald Y.M. Leung+4 more
openalex +1 more source
Impact of Celebrities Disclosing Their Skin Conditions on Public Awareness
JEADV Clinical Practice, EarlyView.
Nicolas Kluger
wiley +1 more source
ABSTRACT In this study, we investigated the pharmacokinetic/pharmacodynamic (PK/PD) relationship of dupilumab as an add‐on therapy in the intent‐to‐treat (ITT) uncontrolled moderate‐to‐severe asthma population and identified the factors significantly contributing to variability in forced expiratory volume in 1 second; (FEV1).
Li Zhang+3 more
wiley +1 more source
ABSTRACT Rocatinlimab (AMG 451/KHK4083) is a potential T‐cell rebalancing therapy that inhibits and reduces the number of pathogenic T cells by targeting the OX40 receptor; it is associated with a progressive and sustained response for patients with moderate‐to‐severe atopic dermatitis (AD).
Hiroki Okada+8 more
wiley +1 more source
Failure of transfer factor therapy in atopic dermatitis
A. Hovmark, HP Ekre
openalex +2 more sources
The schematic illustrates a workflow showing the current investigation using a boronic acid‐functionalized core–shell mesoporous silica‐TiO₂ (CSMS@TiO₂‐GLYMO‐APB) for N‐glycopeptide enrichment from biological samples, involving trypsin digestion, enrichment, deglycosylation with PNGase F, and subsequent mass spectrometry (MALDI‐TOF MS and Nano‐LC‐MS/MS)
Mohamed Adly Gab‐Allah+8 more
wiley +1 more source
Beta Adrenergic Receptor Binding on Polymorphonuclear Leukocytes in Atopic Dermatitis
Stanley P. Galant+3 more
openalex +1 more source